Thioredoxin-Interacting Protein

a Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice

Tauheed Ishrat, Islam N. Mohamed, Bindu Pillai, Sahar Soliman, Abdelrahman Y. Fouda, Adviye Ergul, Azza B. El-Remessy, Susan C. Fagan

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Redox imbalance in the brain significantly contributes to ischemic stroke pathogenesis, but antioxidant therapies have failed in clinical trials. Activation of endogenous defense mechanisms may provide better protection against stroke-induced oxidative injury. TXNIP (thioredoxin-interacting protein) is an endogenous inhibitor of thioredoxin (TRX), a key antioxidant system. We hypothesize that TXNIP inhibition attenuates redox imbalance and inflammation and provides protection against a clinically relevant model of embolic stroke. Male TXNIP-knockout (TKO), wild-type (WT), and WT mice treated with a pharmacological inhibitor of TXNIP, resveratrol (RES; 5 mg/kg body weight), were subjected to embolic middle cerebral artery occlusion (eMCAO). Behavior outcomes were monitored using neurological deficits score and grip strength meter at 24 h after eMCAO. Expression of oxidative, inflammatory, and apoptotic markers was analyzed by Western blot, immunohistochemistry, and slot blot at 24 h post-eMCAO. Our result showed that ischemic injury increases TXNIP in WT mice and that RES inhibits TXNIP expression and protects the brain against ischemic damage. TKO and RES-treated mice exhibited a 39.26 and 41.11 % decrease in infarct size and improved neurological score and grip strength compared to WT mice after eMCAO. Furthermore, the levels of TRX, nitrotyrosine, NOD-like receptor protein (NLRP3), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and activations of caspase-1, caspase-3, and poly-ADP-ribose polymerase (PARP) were significantly (P < 0.05) attenuated in TKO and RES-treated mice. The present study suggests that TXNIP is contributing to acute ischemic stroke through redox imbalance and inflammasome activation and inhibition of TXNIP may provide a new target for therapeutic interventions. This study also affirms the importance of the antioxidant effect of RES on the TRX/TXNIP system.

Original languageEnglish (US)
Pages (from-to)766-778
Number of pages13
JournalMolecular Neurobiology
Volume51
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Thioredoxins
Stroke
Proteins
Middle Cerebral Artery Infarction
Oxidation-Reduction
Antioxidants
Hand Strength
Neuroprotection
Inflammasomes
Caspase 1
Poly(ADP-ribose) Polymerases
Wounds and Injuries
Brain
Defense Mechanisms
Interleukin-1
Caspase 3
Tumor Necrosis Factor-alpha
Western Blotting
Immunohistochemistry
Body Weight

All Science Journal Classification (ASJC) codes

  • Neuroscience (miscellaneous)
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Thioredoxin-Interacting Protein : a Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice. / Ishrat, Tauheed; Mohamed, Islam N.; Pillai, Bindu; Soliman, Sahar; Fouda, Abdelrahman Y.; Ergul, Adviye; El-Remessy, Azza B.; Fagan, Susan C.

In: Molecular Neurobiology, Vol. 51, No. 2, 01.01.2015, p. 766-778.

Research output: Contribution to journalArticle

Ishrat, T, Mohamed, IN, Pillai, B, Soliman, S, Fouda, AY, Ergul, A, El-Remessy, AB & Fagan, SC 2015, 'Thioredoxin-Interacting Protein: a Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice', Molecular Neurobiology, vol. 51, no. 2, pp. 766-778. https://doi.org/10.1007/s12035-014-8766-x
Ishrat, Tauheed ; Mohamed, Islam N. ; Pillai, Bindu ; Soliman, Sahar ; Fouda, Abdelrahman Y. ; Ergul, Adviye ; El-Remessy, Azza B. ; Fagan, Susan C. / Thioredoxin-Interacting Protein : a Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice. In: Molecular Neurobiology. 2015 ; Vol. 51, No. 2. pp. 766-778.
@article{feb9016f7a864aada635f4c038fe171e,
title = "Thioredoxin-Interacting Protein: a Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice",
abstract = "Redox imbalance in the brain significantly contributes to ischemic stroke pathogenesis, but antioxidant therapies have failed in clinical trials. Activation of endogenous defense mechanisms may provide better protection against stroke-induced oxidative injury. TXNIP (thioredoxin-interacting protein) is an endogenous inhibitor of thioredoxin (TRX), a key antioxidant system. We hypothesize that TXNIP inhibition attenuates redox imbalance and inflammation and provides protection against a clinically relevant model of embolic stroke. Male TXNIP-knockout (TKO), wild-type (WT), and WT mice treated with a pharmacological inhibitor of TXNIP, resveratrol (RES; 5 mg/kg body weight), were subjected to embolic middle cerebral artery occlusion (eMCAO). Behavior outcomes were monitored using neurological deficits score and grip strength meter at 24 h after eMCAO. Expression of oxidative, inflammatory, and apoptotic markers was analyzed by Western blot, immunohistochemistry, and slot blot at 24 h post-eMCAO. Our result showed that ischemic injury increases TXNIP in WT mice and that RES inhibits TXNIP expression and protects the brain against ischemic damage. TKO and RES-treated mice exhibited a 39.26 and 41.11 {\%} decrease in infarct size and improved neurological score and grip strength compared to WT mice after eMCAO. Furthermore, the levels of TRX, nitrotyrosine, NOD-like receptor protein (NLRP3), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and activations of caspase-1, caspase-3, and poly-ADP-ribose polymerase (PARP) were significantly (P < 0.05) attenuated in TKO and RES-treated mice. The present study suggests that TXNIP is contributing to acute ischemic stroke through redox imbalance and inflammasome activation and inhibition of TXNIP may provide a new target for therapeutic interventions. This study also affirms the importance of the antioxidant effect of RES on the TRX/TXNIP system.",
author = "Tauheed Ishrat and Mohamed, {Islam N.} and Bindu Pillai and Sahar Soliman and Fouda, {Abdelrahman Y.} and Adviye Ergul and El-Remessy, {Azza B.} and Fagan, {Susan C.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/s12035-014-8766-x",
language = "English (US)",
volume = "51",
pages = "766--778",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Thioredoxin-Interacting Protein

T2 - a Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice

AU - Ishrat, Tauheed

AU - Mohamed, Islam N.

AU - Pillai, Bindu

AU - Soliman, Sahar

AU - Fouda, Abdelrahman Y.

AU - Ergul, Adviye

AU - El-Remessy, Azza B.

AU - Fagan, Susan C.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Redox imbalance in the brain significantly contributes to ischemic stroke pathogenesis, but antioxidant therapies have failed in clinical trials. Activation of endogenous defense mechanisms may provide better protection against stroke-induced oxidative injury. TXNIP (thioredoxin-interacting protein) is an endogenous inhibitor of thioredoxin (TRX), a key antioxidant system. We hypothesize that TXNIP inhibition attenuates redox imbalance and inflammation and provides protection against a clinically relevant model of embolic stroke. Male TXNIP-knockout (TKO), wild-type (WT), and WT mice treated with a pharmacological inhibitor of TXNIP, resveratrol (RES; 5 mg/kg body weight), were subjected to embolic middle cerebral artery occlusion (eMCAO). Behavior outcomes were monitored using neurological deficits score and grip strength meter at 24 h after eMCAO. Expression of oxidative, inflammatory, and apoptotic markers was analyzed by Western blot, immunohistochemistry, and slot blot at 24 h post-eMCAO. Our result showed that ischemic injury increases TXNIP in WT mice and that RES inhibits TXNIP expression and protects the brain against ischemic damage. TKO and RES-treated mice exhibited a 39.26 and 41.11 % decrease in infarct size and improved neurological score and grip strength compared to WT mice after eMCAO. Furthermore, the levels of TRX, nitrotyrosine, NOD-like receptor protein (NLRP3), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and activations of caspase-1, caspase-3, and poly-ADP-ribose polymerase (PARP) were significantly (P < 0.05) attenuated in TKO and RES-treated mice. The present study suggests that TXNIP is contributing to acute ischemic stroke through redox imbalance and inflammasome activation and inhibition of TXNIP may provide a new target for therapeutic interventions. This study also affirms the importance of the antioxidant effect of RES on the TRX/TXNIP system.

AB - Redox imbalance in the brain significantly contributes to ischemic stroke pathogenesis, but antioxidant therapies have failed in clinical trials. Activation of endogenous defense mechanisms may provide better protection against stroke-induced oxidative injury. TXNIP (thioredoxin-interacting protein) is an endogenous inhibitor of thioredoxin (TRX), a key antioxidant system. We hypothesize that TXNIP inhibition attenuates redox imbalance and inflammation and provides protection against a clinically relevant model of embolic stroke. Male TXNIP-knockout (TKO), wild-type (WT), and WT mice treated with a pharmacological inhibitor of TXNIP, resveratrol (RES; 5 mg/kg body weight), were subjected to embolic middle cerebral artery occlusion (eMCAO). Behavior outcomes were monitored using neurological deficits score and grip strength meter at 24 h after eMCAO. Expression of oxidative, inflammatory, and apoptotic markers was analyzed by Western blot, immunohistochemistry, and slot blot at 24 h post-eMCAO. Our result showed that ischemic injury increases TXNIP in WT mice and that RES inhibits TXNIP expression and protects the brain against ischemic damage. TKO and RES-treated mice exhibited a 39.26 and 41.11 % decrease in infarct size and improved neurological score and grip strength compared to WT mice after eMCAO. Furthermore, the levels of TRX, nitrotyrosine, NOD-like receptor protein (NLRP3), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and activations of caspase-1, caspase-3, and poly-ADP-ribose polymerase (PARP) were significantly (P < 0.05) attenuated in TKO and RES-treated mice. The present study suggests that TXNIP is contributing to acute ischemic stroke through redox imbalance and inflammasome activation and inhibition of TXNIP may provide a new target for therapeutic interventions. This study also affirms the importance of the antioxidant effect of RES on the TRX/TXNIP system.

UR - http://www.scopus.com/inward/record.url?scp=84939779243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939779243&partnerID=8YFLogxK

U2 - 10.1007/s12035-014-8766-x

DO - 10.1007/s12035-014-8766-x

M3 - Article

VL - 51

SP - 766

EP - 778

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

IS - 2

ER -